EUVIMEDEUVIMED entdecken
Crossref

Glycosylated derivatives of icaritin: Synthesis, glycosyl substitution properties, anti-liver cancer activity evaluation and structure-activity relationship studies

Yan Liu, Wenli Cao, Shuwen Yang, Linbo Lv, Shuangli Wang, Weiwei Zhang, Guo-Dong Yao, Qingbo Liu, Shao-Jiang Song

Bioorganic Chemistry · 2026-11 · 184 · 110680

DOI: 10.1016/j.bioorg.2026.110680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Yan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province; Engineering Research Center of Natu…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Liver Neoplasms, Flavonoids, Glycosides. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Icaritin (ICT), a clinically approved natural anti-liver cancer agent, exhibits pharmacological limitations. To enhance its activity, glycosylation was performed at the 3-OH and 7-OH positions using five monosaccharides, and a total of 31 ICT O-glycosylated derivatives were synthesized in a stereoselective manner. In vitro evaluation showed that most glycosides markedly inhibited the proliferation of Hep3B and HepG2 cells. Structure-activity relationship (SAR) analysis indicated that acetylation of the glycosyl moiety could enhance the inhibitory activity. The 3-O-glycosides demonstrated stronger inhibition of Hep3B cells than the 7-O-glycosides, whereas the opposite trend was observed in HepG2 and Huh7 cells, while the doubly substituted 3,7-O-glycosides exhibited consistently weaker activity in three cell lines. Notably, the 7-O-acetyl galactoside 2b (Hep3B: IC50 = 0.18 μM; HepG2: IC50 = 2.60 μM; Huh7: IC50 = 6.66 μM) exhibited superior anti-liver cancer activity across three cell lines compared with ICT and sorafenib (SOR). Further studies demonstrated that 2b induced G0/G1 phase arrest and enhanced oxidative stress in HepG2 cells. Initial mechanistic studies indicated that 2b was able to bind to Ataxia telangiectasia and Rad3-related protein (ATR) in HepG2 cells, inhibit the ATR/Chk1 signaling axis, and induce DNA damage. In zebrafish HepG2 xenografts, 2b displayed exhibited preferential cytotoxicity toward tumor cells and produced a dose-dependent suppression of tumor growth, further confirming its superior in vivo efficacy. These results demonstrate the potential of ICT glycosylated derivatives as lead anti-liver cancer compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsLiver NeoplasmsFlavonoidsGlycosidesHumansStructure-Activity RelationshipGlycosylationCell ProliferationDrug Screening Assays, AntitumorAnimalsDose-Response Relationship, DrugMolecular StructureZebrafishCell Line, Tumor

Stichwörter der Autor:innen

Anti-liver cancerAtaxia telangiectasia and Rad3-related proteinGlycosylationIcaritinStructure-activity relationship studies

Substanzen

icaritinAntineoplastic AgentsFlavonoidsGlycosides

Autor:innen und Institutionen

  • Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province; Engineering Research Center of Natural Medicine Active Molecule Research & Development, Liaoning Province…

Zitieren

APA

Liu, Y., Cao, W., Yang, S., Lv, L., Wang, S., Zhang, W., Yao, G. D., Liu, Q., & Song, S. J. (2026). Glycosylated derivatives of icaritin: Synthesis, glycosyl substitution properties, anti-liver cancer activity evaluation and structure-activity relationship studies. Bioorganic Chemistry, 184, 110680. https://doi.org/10.1016/j.bioorg.2026.110680

Vancouver

Liu Y, Cao W, Yang S, Lv L, Wang S, Zhang W, et al. Glycosylated derivatives of icaritin: Synthesis, glycosyl substitution properties, anti-liver cancer activity evaluation and structure-activity relationship studies. Bioorganic Chemistry. 2026;184:110680. doi:10.1016/j.bioorg.2026.110680

BibTeX
@article{Liu2026,
  author = {Liu, Yan and Cao, Wenli and Yang, Shuwen and Lv, Linbo and Wang, Shuangli and Zhang, Weiwei and Yao, Guo-Dong and Liu, Qingbo and Song, Shao-Jiang},
  title = {Glycosylated derivatives of icaritin: Synthesis, glycosyl substitution properties, anti-liver cancer activity evaluation and structure-activity relationship studies},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {184},
  pages = {110680},
  doi = {10.1016/j.bioorg.2026.110680}
}
Kostenlos starten →